- MY ACCOUNT
Title: Elimination of triggers without an additional substrate modification is not sufficient in patients with persistent atrial fibrillation
Title: The Safety of Dabigatran Versus Warfarin in Patients Undergoing Atrial Fibrillation Ablation
Credits: Luis I. Garcia, MD, Kartikya Ahuja, MD, Mark A. Mascarenhas, MD, Anthony Aizer, MD, Neil Bernstein, MD, Scott A. Bernstein, MD, Steve J. Fowler, MD, Douglas S. Holmes, MD, David S. Park, MD, Larry Chinitz, MD
Title: Atrial Fibrillation and Heart Failure: A Review of the Intersection of Two Cardiac Epidemics
Title: Atrial Fibrillation after Radiofrequency Ablation of Type I Atrial Flutter
Affiliation: Executive Medical Director, The Kansas City Heart Rhythm Institute (KCHRI) @ HCA MidWest 12200, W 106th street, Overland Park Regional Medical Center Overland Park, KS 66215
Affiliation: Dr Junbeom Park is board certified in Internal Medicine, Cardiology and Clinical Cardiac Electrophysiology. He had been on Assistant Clinical Research Professor at Arrhythmia Center, Cardiovascular Hospital, Yonsei University Health System (2012-2015). Currently, he has been Assistant Professor at Ewha Womans University Medical Center since 2015. Dr Junbeom’s procedural and research includes catheter ablation of supraventricular and ventricular arrhythmias and implantation of cardiac devices and lead extraction.
Affiliation: Dr Park Chan-il received his M.D. from the faculty of Medicine, Geneva University in 2002. He started his training is cardiac electrophysiology at Geneva University hospital in Switzerland. He is currently a Senior Electrophysiology Fellow at University Heart Center of Freiburg-Bad Krozingen, Bad Krozingen, Germany.
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...